Alan Tuchman
Chief Executive Officer chez NEUROTROPE, INC.
Fortune : 6 204 $ au 31/03/2024
Profil
Alan J.
Tuchman founded MedPro Investors LLC in 2011, where he worked as Managing Director from 2011 to 2020.
Dr. Tuchman also currently works at Neurotrope, Inc., as Chief Executive Officer, Synaptogenix, Inc., as Chief Executive & Medical Officer, Director, and New York Medical College, as Clinical Professor-Neurology.
Dr. Tuchman also formerly worked at Neurophysics Corp., as Executive Chairman & Chief Executive Officer from 2002 to 2010, Cordex Pharma, Inc., as Director, Oscar Gruss & Son, Inc., as Senior Vice President from 1997 to 2000, Oncolytics Biotech, Inc., as Chief Neuro Oncology Research Officer from 2016 to 2017, Xmark Opportunity Partners LLC, as Partner from 2002 to 2007, Lincoln Medical Center, as Senior Neurologist-Medical & Mental Health, and Epilepsy Society of Southern New York, as President from 1992 to 1996.
Dr. Tuchman received his Masters Business Admin degree in 1996 from The Trustees of Columbia University in The City of New York and doctorate degree from The University of Cincinnati College of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SYNAPTOGENIX, INC.
0,16% | 25/03/2024 | 33 000 ( 0,16% ) | 6 204 $ | 31/03/2024 |
Postes actifs de Alan Tuchman
| Sociétés | Poste | Début |
|---|---|---|
| NEUROTROPE, INC. | Chief Executive Officer | - |
| SYNAPTOGENIX, INC. | Chief Executive Officer | 07/12/2020 |
| New York Medical College | Corporate Officer/Principal | 01/01/1995 |
Anciens postes connus de Alan Tuchman
| Sociétés | Poste | Fin |
|---|---|---|
| MedPro Investors LLC | Founder | 02/01/2011 |
| ONCOLYTICS BIOTECH INC. | Chief Tech/Sci/R&D Officer | 10/11/2016 |
| Neurophysics Corp. | Chief Executive Officer | 01/01/2010 |
Oscar Gruss & Son, Inc.
 Oscar Gruss & Son, Inc. Investment Banks/BrokersFinance Founded in 1947 by Oscar Gruss and Emanuel Gruss, Oscar Gruss & Son, Inc. is a full-service broker/dealer located in New York City. The firm offers focused independent research and trading and execution services focusing particularly on special situations and convertibles. They conduct business with major Israeli institutional clients who execute trades in U.S. equities and options. Oscar Gruss & Son also maintains a trading desk in New York solely dedicated to European investors. The firm is a member of the NYSE and the SIPC. | Analyst-Equity | 31/12/2000 |
| Epilepsy Society of Southern New York | President | 01/01/1996 |
Formation de Alan Tuchman
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| The University of Cincinnati College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ONCOLYTICS BIOTECH INC. | Health Technology |
| SYNAPTOGENIX, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Oscar Gruss & Son, Inc.
Oscar Gruss & Son, Inc. Investment Banks/BrokersFinance Founded in 1947 by Oscar Gruss and Emanuel Gruss, Oscar Gruss & Son, Inc. is a full-service broker/dealer located in New York City. The firm offers focused independent research and trading and execution services focusing particularly on special situations and convertibles. They conduct business with major Israeli institutional clients who execute trades in U.S. equities and options. Oscar Gruss & Son also maintains a trading desk in New York solely dedicated to European investors. The firm is a member of the NYSE and the SIPC. | Finance |
Xmark Opportunity Partners LLC
 Xmark Opportunity Partners LLC Investment ManagersFinance Founded in 2001 by Mitchell Kaye, Xmark Opportunity Partners LLC is a hedge fund company located in Ridgefield, Connecticut | Finance |
Neurotrope, Inc.
 Neurotrope, Inc. Pharmaceuticals: MajorHealth Technology Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY. | Health Technology |
Cordex Pharma, Inc.
 Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Health Technology |
Lincoln Medical Center
 Lincoln Medical Center Hospital/Nursing ManagementHealth Services Lincoln Medical Center provided general medical services for the residents of Lincoln County, North Carolina. Specialty services include home health, imaging, surgery, a sleep center and heart care. The medical center also offered pain management services, a birthing center and outpatient diabetes services. The company was located in Lincolnton, NC. | Health Services |
| Neurophysics Corp. | |
| Epilepsy Society of Southern New York | |
| MedPro Investors LLC |
